ID   SYRC_HUMAN              Reviewed;         660 AA.
AC   P54136; B2RBS9; Q53GY4; Q9BWA1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2002, sequence version 2.
DT   10-MAY-2017, entry version 173.
DE   RecName: Full=Arginine--tRNA ligase, cytoplasmic;
DE            EC=6.1.1.19;
DE   AltName: Full=Arginyl-tRNA synthetase;
DE            Short=ArgRS;
GN   Name=RARS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7590355; DOI=10.1016/0378-1119(95)00502-W;
RA   Girjes A.A., Hobson K., Chen P., Lavin M.F.;
RT   "Cloning and characterization of cDNA encoding a human arginyl-tRNA
RT   synthetase.";
RL   Gene 164:347-350(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-11.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   INTERACTION WITH AIMP1.
RX   PubMed=10358004; DOI=10.1074/jbc.274.24.16673;
RA   Park S.G., Jung K.H., Lee J.S., Jo Y.J., Motegi H., Kim S., Shiba K.;
RT   "Precursor of pro-apoptotic cytokine modulates aminoacylation activity
RT   of tRNA synthetase.";
RL   J. Biol. Chem. 274:16673-16676(1999).
RN   [8]
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, AND INTERACTION
RP   WITH LARS2.
RX   PubMed=16055448; DOI=10.1074/jbc.M413511200;
RA   Ling C., Yao Y.N., Zheng Y.G., Wei H., Wang L., Wu X.F., Wang E.D.;
RT   "The C-terminal appended domain of human cytosolic leucyl-tRNA
RT   synthetase is indispensable in its interaction with arginyl-tRNA
RT   synthetase in the multi-tRNA synthetase complex.";
RL   J. Biol. Chem. 280:34755-34763(2005).
RN   [9]
RP   SUBCELLULAR LOCATION, AND ALTERNATIVE INITIATION.
RX   PubMed=16430231; DOI=10.1021/bi051675n;
RA   Zheng Y.-G., Wei H., Ling C., Xu M.-G., Wang E.-D.;
RT   "Two forms of human cytoplasmic arginyl-tRNA synthetase produced from
RT   two translation initiations by a single mRNA.";
RL   Biochemistry 45:1338-1344(2006).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH AIMP1.
RX   PubMed=17443684; DOI=10.1002/jcp.21083;
RA   Bottoni A., Vignali C., Piccin D., Tagliati F., Luchin A.,
RA   Zatelli M.C., Uberti E.C.;
RT   "Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer
RT   cell lines.";
RL   J. Cell. Physiol. 212:293-297(2007).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   INTERACTION WITH QARS.
RX   PubMed=24656866; DOI=10.1016/j.ajhg.2014.03.003;
RA   Zhang X., Ling J., Barcia G., Jing L., Wu J., Barry B.J.,
RA   Mochida G.H., Hill R.S., Weimer J.M., Stein Q., Poduri A.,
RA   Partlow J.N., Ville D., Dulac O., Yu T.W., Lam A.T., Servattalab S.,
RA   Rodriguez J., Boddaert N., Munnich A., Colleaux L., Zon L.I., Soll D.,
RA   Walsh C.A., Nabbout R.;
RT   "Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause
RT   progressive microcephaly, cerebral-cerebellar atrophy, and intractable
RT   seizures.";
RL   Am. J. Hum. Genet. 94:547-558(2014).
RN   [17]
RP   INVOLVEMENT IN HLD9, AND VARIANTS HLD9 GLY-2 AND GLN-512.
RX   PubMed=24777941; DOI=10.1002/ana.24167;
RA   Wolf N.I., Salomons G.S., Rodenburg R.J., Pouwels P.J.,
RA   Schieving J.H., Derks T.G., Fock J.M., Rump P., van Beek D.M.,
RA   van der Knaap M.S., Waisfisz Q.;
RT   "Mutations in RARS cause hypomyelination.";
RL   Ann. Neurol. 76:134-139(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Forms part of a macromolecular complex that catalyzes
CC       the attachment of specific amino acids to cognate tRNAs during
CC       protein synthesis. Modulates the secretion of AIMP1 and may be
CC       involved in generation of the inflammatory cytokine EMAP2 from
CC       AIMP1. {ECO:0000269|PubMed:17443684}.
CC   -!- CATALYTIC ACTIVITY: ATP + L-arginine + tRNA(Arg) = AMP +
CC       diphosphate + L-arginyl-tRNA(Arg).
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.9 uM for arginine (ATP-PPi exchange at 37 degrees Celsius)
CC         {ECO:0000269|PubMed:16055448};
CC         KM=3.5 uM for arginine (arginylation at 37 degrees Celsius)
CC         {ECO:0000269|PubMed:16055448};
CC         KM=1183 uM for ATP (ATP-PPi exchange at 37 Celsius)
CC         {ECO:0000269|PubMed:16055448};
CC         KM=910 uM for ATP (arginylation at 37 Celsius)
CC         {ECO:0000269|PubMed:16055448};
CC         KM=0.05 uM for calf liver tRNA-Arg (ATP-PPi exchange at 37
CC         Celsius) {ECO:0000269|PubMed:16055448};
CC         KM=0.41 uM for calf liver tRNA-Arg (arginylation at 37 Celsius)
CC         {ECO:0000269|PubMed:16055448};
CC   -!- SUBUNIT: Interacts (via N-terminus) with AIMP1 (via N-terminus);
CC       this stimulates its catalytic activity. Interacts (via N-terminus)
CC       with LARS2 (via C-terminus). Monomer; also part of a multisubunit
CC       complex that groups tRNA ligases for Arg, Asp, Glu, Gln, Ile, Leu,
CC       Lys, Met and Pro. Interacts with QARS.
CC       {ECO:0000269|PubMed:10358004, ECO:0000269|PubMed:16055448,
CC       ECO:0000269|PubMed:17443684, ECO:0000269|PubMed:24656866}.
CC   -!- INTERACTION:
CC       Q9P2J5:LARS; NbExp=3; IntAct=EBI-355482, EBI-356077;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16055448,
CC       ECO:0000269|PubMed:16430231}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Complexed;
CC         IsoId=P54136-1; Sequence=Displayed;
CC       Name=Monomeric;
CC         IsoId=P54136-2; Sequence=VSP_018905;
CC   -!- DOMAIN: The N-terminus (AA 1-72) has two regions predicted to be
CC       alpha-helical that might be involved in the multisynthetase
CC       complex assembly.
CC   -!- DISEASE: Leukodystrophy, hypomyelinating, 9 (HLD9) [MIM:616140]:
CC       An autosomal recessive neurodegenerative disorder characterized by
CC       delayed psychomotor development, severe spasticity, nystagmus, and
CC       ataxia associated with diffuse hypomyelination apparent on brain
CC       MRI. {ECO:0000269|PubMed:24777941}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S80343; AAB35627.1; -; mRNA.
DR   EMBL; BT007394; AAP36058.1; -; mRNA.
DR   EMBL; AK314795; BAG37326.1; -; mRNA.
DR   EMBL; AK222797; BAD96517.1; -; mRNA.
DR   EMBL; BC000528; AAH00528.1; -; mRNA.
DR   EMBL; BC014619; AAH14619.1; -; mRNA.
DR   CCDS; CCDS4367.1; -. [P54136-1]
DR   PIR; JC4365; JC4365.
DR   RefSeq; NP_002878.2; NM_002887.3. [P54136-1]
DR   UniGene; Hs.654907; -.
DR   PDB; 4Q2T; X-ray; 2.40 A; A/B=73-660.
DR   PDB; 4Q2X; X-ray; 2.80 A; A/B=73-660.
DR   PDB; 4Q2Y; X-ray; 2.80 A; A/B=73-660.
DR   PDB; 4R3Z; X-ray; 4.03 A; B=1-660.
DR   PDB; 4ZAJ; X-ray; 2.22 A; A=73-660.
DR   PDBsum; 4Q2T; -.
DR   PDBsum; 4Q2X; -.
DR   PDBsum; 4Q2Y; -.
DR   PDBsum; 4R3Z; -.
DR   PDBsum; 4ZAJ; -.
DR   ProteinModelPortal; P54136; -.
DR   SMR; P54136; -.
DR   BioGrid; 111852; 61.
DR   IntAct; P54136; 16.
DR   MINT; MINT-5006018; -.
DR   STRING; 9606.ENSP00000231572; -.
DR   BindingDB; P54136; -.
DR   ChEMBL; CHEMBL2824; -.
DR   iPTMnet; P54136; -.
DR   PhosphoSitePlus; P54136; -.
DR   SwissPalm; P54136; -.
DR   BioMuta; RARS; -.
DR   DMDM; 20178331; -.
DR   EPD; P54136; -.
DR   MaxQB; P54136; -.
DR   PaxDb; P54136; -.
DR   PeptideAtlas; P54136; -.
DR   PRIDE; P54136; -.
DR   DNASU; 5917; -.
DR   Ensembl; ENST00000231572; ENSP00000231572; ENSG00000113643. [P54136-1]
DR   GeneID; 5917; -.
DR   KEGG; hsa:5917; -.
DR   UCSC; uc003lzx.4; human. [P54136-1]
DR   CTD; 5917; -.
DR   DisGeNET; 5917; -.
DR   GeneCards; RARS; -.
DR   HGNC; HGNC:9870; RARS.
DR   HPA; HPA003979; -.
DR   HPA; HPA004130; -.
DR   MalaCards; RARS; -.
DR   MIM; 107820; gene.
DR   MIM; 616140; phenotype.
DR   neXtProt; NX_P54136; -.
DR   OpenTargets; ENSG00000113643; -.
DR   PharmGKB; PA34231; -.
DR   eggNOG; KOG1195; Eukaryota.
DR   eggNOG; COG0018; LUCA.
DR   GeneTree; ENSGT00530000063407; -.
DR   HOGENOM; HOG000247212; -.
DR   HOVERGEN; HBG029238; -.
DR   InParanoid; P54136; -.
DR   KO; K01887; -.
DR   OMA; TAMFLLY; -.
DR   OrthoDB; EOG091G03A6; -.
DR   PhylomeDB; P54136; -.
DR   TreeFam; TF106111; -.
DR   Reactome; R-HSA-2408517; SeMet incorporation into proteins.
DR   Reactome; R-HSA-379716; Cytosolic tRNA aminoacylation.
DR   ChiTaRS; RARS; human.
DR   GeneWiki; RARS_(gene); -.
DR   GenomeRNAi; 5917; -.
DR   PRO; PR:P54136; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000113643; -.
DR   CleanEx; HS_RARS; -.
DR   ExpressionAtlas; P54136; baseline and differential.
DR   Genevisible; P54136; HS.
DR   GO; GO:0017101; C:aminoacyl-tRNA synthetase multienzyme complex; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:CAFA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:CAFA.
DR   GO; GO:0034618; F:arginine binding; IEA:Ensembl.
DR   GO; GO:0004814; F:arginine-tRNA ligase activity; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0000049; F:tRNA binding; IEA:Ensembl.
DR   GO; GO:0006420; P:arginyl-tRNA aminoacylation; IBA:GO_Central.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome.
DR   Gene3D; 1.10.730.10; -; 1.
DR   Gene3D; 3.30.1360.70; -; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   HAMAP; MF_00123; Arg_tRNA_synth; 1.
DR   InterPro; IPR001412; aa-tRNA-synth_I_CS.
DR   InterPro; IPR001278; Arg-tRNA-ligase.
DR   InterPro; IPR005148; Arg-tRNA-synth_N.
DR   InterPro; IPR008909; DALR_anticod-bd.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   PANTHER; PTHR11956; PTHR11956; 1.
DR   Pfam; PF03485; Arg_tRNA_synt_N; 1.
DR   Pfam; PF05746; DALR_1; 1.
DR   Pfam; PF00750; tRNA-synt_1d; 1.
DR   PRINTS; PR01038; TRNASYNTHARG.
DR   SMART; SM01016; Arg_tRNA_synt_N; 1.
DR   SMART; SM00836; DALR_1; 1.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   SUPFAM; SSF55190; SSF55190; 1.
DR   TIGRFAMs; TIGR00456; argS; 1.
DR   PROSITE; PS00178; AA_TRNA_LIGASE_I; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation;
KW   Aminoacyl-tRNA synthetase; ATP-binding; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; Leukodystrophy; Ligase;
KW   Nucleotide-binding; Polymorphism; Protein biosynthesis;
KW   Reference proteome.
FT   CHAIN         1    660       Arginine--tRNA ligase, cytoplasmic.
FT                                /FTId=PRO_0000035797.
FT   REGION        1     72       Could be involved in the assembly of the
FT                                multisynthetase complex.
FT   MOTIF       201    212       "HIGH" region.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   VAR_SEQ       1     72       Missing (in isoform Monomeric).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_018905.
FT   VARIANT       2      2       D -> G (in HLD9; dbSNP:rs672601372).
FT                                {ECO:0000269|PubMed:24777941}.
FT                                /FTId=VAR_072666.
FT   VARIANT       3      3       V -> I (in dbSNP:rs244903).
FT                                /FTId=VAR_020106.
FT   VARIANT     135    135       R -> G (in dbSNP:rs1059443).
FT                                /FTId=VAR_052635.
FT   VARIANT     397    397       F -> Y (in dbSNP:rs2305734).
FT                                /FTId=VAR_020107.
FT   VARIANT     512    512       R -> Q (in HLD9; dbSNP:rs369398935).
FT                                {ECO:0000269|PubMed:24777941}.
FT                                /FTId=VAR_072667.
FT   CONFLICT     39     39       P -> S (in Ref. 1; AAB35627).
FT                                {ECO:0000305}.
FT   CONFLICT    130    131       QK -> PE (in Ref. 1; AAB35627).
FT                                {ECO:0000305}.
FT   CONFLICT    135    137       REI -> GEF (in Ref. 1; AAB35627).
FT                                {ECO:0000305}.
FT   CONFLICT    147    156       DNECIEKVEI -> AMDVLKRVEF (in Ref. 1;
FT                                AAB35627). {ECO:0000305}.
FT   CONFLICT    164    164       V -> G (in Ref. 1; AAB35627).
FT                                {ECO:0000305}.
FT   CONFLICT    278    278       K -> N (in Ref. 3; BAG37326).
FT                                {ECO:0000305}.
FT   CONFLICT    308    312       WKLIC -> YLLMS (in Ref. 1; AAB35627).
FT                                {ECO:0000305}.
FT   CONFLICT    341    341       R -> G (in Ref. 4; BAD96517).
FT                                {ECO:0000305}.
FT   CONFLICT    358    358       D -> G (in Ref. 3; BAG37326).
FT                                {ECO:0000305}.
FT   CONFLICT    487    487       T -> A (in Ref. 4; BAD96517).
FT                                {ECO:0000305}.
FT   CONFLICT    567    567       D -> V (in Ref. 1; AAB35627).
FT                                {ECO:0000305}.
FT   CONFLICT    635    640       MLLCEA -> ILCET (in Ref. 1; AAB35627).
FT                                {ECO:0000305}.
FT   CONFLICT    651    651       I -> T (in Ref. 1; AAB35627).
FT                                {ECO:0000305}.
FT   CONFLICT    657    660       VQRM -> GPRV (in Ref. 1; AAB35627).
FT                                {ECO:0000305}.
FT   HELIX        76     91       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      102    104       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      108    110       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      112    115       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       117    123       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       134    143       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      149    155       {ECO:0000244|PDB:4ZAJ}.
FT   TURN        158    160       {ECO:0000244|PDB:4Q2T}.
FT   STRAND      162    166       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       168    181       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      193    197       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       209    227       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      231    236       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      241    243       {ECO:0000244|PDB:4Q2T}.
FT   HELIX       244    255       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       257    260       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       269    282       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       285    298       {ECO:0000244|PDB:4ZAJ}.
FT   TURN        302    304       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       305    325       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       335    341       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       342    351       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      355    358       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      361    364       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      373    376       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       384    397       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      402    409       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       410    412       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       413    425       {ECO:0000244|PDB:4ZAJ}.
FT   TURN        431    433       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      434    441       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      449    451       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      455    458       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       462    478       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      482    485       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       487    490       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       493    508       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      512    514       {ECO:0000244|PDB:4Q2X}.
FT   HELIX       520    523       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      526    530       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       531    546       {ECO:0000244|PDB:4ZAJ}.
FT   TURN        547    549       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       552    561       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       569    578       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       581    591       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       595    614       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      617    620       {ECO:0000244|PDB:4ZAJ}.
FT   TURN        622    624       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      627    630       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       632    652       {ECO:0000244|PDB:4ZAJ}.
SQ   SEQUENCE   660 AA;  75379 MW;  FE9FB5C910709956 CRC64;
     MDVLVSECSA RLLQQEEEIK SLTAEIDRLK NCGCLGASPN LEQLQEENLK LKYRLNILRK
     SLQAERNKPT KNMINIISRL QEVFGHAIKA AYPDLENPPL LVTPSQQAKF GDYQCNSAMG
     ISQMLKTKEQ KVNPREIAEN ITKHLPDNEC IEKVEIAGPG FINVHLRKDF VSEQLTSLLV
     NGVQLPALGE NKKVIVDFSS PNIAKEMHVG HLRSTIIGES ISRLFEFAGY DVLRLNHVGD
     WGTQFGMLIA HLQDKFPDYL TVSPPIGDLQ VFYKESKKRF DTEEEFKKRA YQCVVLLQGK
     NPDITKAWKL ICDVSRQELN KIYDALDVSL IERGESFYQD RMNDIVKEFE DRGFVQVDDG
     RKIVFVPGCS IPLTIVKSDG GYTYDTSDLA AIKQRLFEEK ADMIIYVVDN GQSVHFQTIF
     AAAQMIGWYD PKVTRVFHAG FGVVLGEDKK KFKTRSGETV RLMDLLGEGL KRSMDKLKEK
     ERDKVLTAEE LNAAQTSVAY GCIKYADLSH NRLNDYIFSF DKMLDDRGNT AAYLLYAFTR
     IRSIARLANI DEEMLQKAAR ETKILLDHEK EWKLGRCILR FPEILQKILD DLFLHTLCDY
     IYELATAFTE FYDSCYCVEK DRQTGKILKV NMWRMLLCEA VAAVMAKGFD ILGIKPVQRM
//
